Researchers track Real-World use of Prader-Willi drug
NCT ID NCT07450664
Summary
This study aims to gather more information about the safety and effects of the medication VYKAT XR in people with Prader-Willi syndrome. It will follow about 200 patients who are already taking or starting to take this medication in their regular care. The study is observational, meaning it watches and records what happens during normal treatment without changing how patients are managed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Sparrow Clinical Research Institute
Lansing, Michigan, 48912, United States
Conditions
Explore the condition pages connected to this study.